Download the Brochure for More Details@ https://www.marketsandmarkets.com/pdfdownload.asp?id=89198891
The key factors propelling the growth of this market include growth in the median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility and the available treatment options. However, the high cost and low success rate of the IVF treatment and restrictive regulation and ethical concerns are expected to restrict the growth of market to a certain extent.
Base year considered for the report is 2016 and the forecast period is 2017–2022.
Objectives of the Study:
# To define, describe, and forecast the global in vitro fertilization market with respect to type of cycle, product, end user, and region.
# To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges).
# To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market.
# To analyze market opportunities for stakeholders and provide details of the competitive landscape of market leaders.
# To forecast the size of the global market with respect to four main regions—North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW).
# To profile the key players in the global market and comprehensively analyze their core competencies.
# To track and analyze competitive developments such as agreements and partnerships, mergers, acquisitions, reprocessed medical device developments, and service launches of the leading players in the in vitro fertilization market.
Asia Pacific dominated the market in 2017
Asia Pacific is expected to dominate the global in vitro fertilization market in 2017. The large share and high growth rate of the APAC region can be attributed growth in the median age of first-time motherhood, rising infertility rates, growing prevalence of PCOS, increasing incidence of obesity, rise in fertility tourism, and government initiatives.
CooperSurgical (US), Vitrolife (Sweden), Cook Medical (US), Irvine Scientific (US), and Thermo Fisher Scientific (US) are the major players in the in vitro fertilization market. Other players include Esco Micro (Singapore), IVFtech (Denmark), EMD Sereno (US), Genea Limited (Australia), Rocket Medical (UK), and Nidacon International (Sweden).
No comments:
Post a Comment